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ABSTRACT 
Hearing is one of our main sensory systems and having a hearing disorder, 
although not life threatening, can have a disturbing impact in an individual’s quality 
of life. Approximately 49 million Americans suffer from some form of hearing loss. 
Sensory neural hearing loss (SNHL) is the most common form, which results from 
degeneration of inner ear sensory hair cells and auditory neurons in the cochlea. In 
recent years, there has been an increasing interest in gene delivery to mesenchymal 
stem cells. Gene delivery approaches to stem cells can provide an opportunity to 
engineer a variety of specialized cell types. The objective of this thesis was to 
evaluate the potential of human umbilical cord mesenchymal stromal cells
(hUCMSCs) as a possible source for regenerating inner ear hair cells. This thesis was 
successful in developing an adenoviral mediated gene delivery approach to deliver 
the Math1 gene to hUCMSCs. The expression of Math1 induced the differentiation of 
hUCMSCs into cells that resembled inner ear hair cells morphologically and 
immunocytochemically, evidenced by the expression of hair cell-specific and glial 
cell markers. The results obtained in this thesis demonstrated for the first time that 
hUCMSCs can differentiate into hair cell-like cells, thus introducing a potential tissue 
engineering and cell transplantation approach for the treatment of hearing loss. 
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CHAPTER 1: Introduction 
The overall objective of this thesis was to demonstrate the feasibility of 
transducing human umbilical cord mesenchymal stromal cells (hUCMSCs) using 
adenoviral vectors, and to differentiate them in vitro into a hair cell-like cell through 
adenoviral mediated gene delivery of the Math1 gene.  To achieve this objective, two 
phases were recognized - feasibility phase and differentiation phase. In the feasibility 
phase, the objective was to transduce hUCMSCs using different adenoviral serotypes 
(Ad5 and Ad28) and to compare transduction efficiencies between these differ nt 
serotypes. The next phase was the differentiation phase, which was to induce inner 
ear hair cell differentiation in hUCMSCs and to characterize the properties of the 
differentiated cells. The feasibility phase provided information about the ability of 
hUCMSCs to express genes delivered through an adenoviral vector. In the 
differentiation phase, the cells were first tested for their ab lity to respond to the 
transcription factor Math1 with vectors driven by the human cytomegalovirus 
(hCMV) promoter and the glial fibrillary acidic protein (GFAP) promoter. The cells 
were then differentiated in vitro using the vector with an hCMV promoter. 
Differentiation of hUCMSCs was characterized according to morphology and 
immunocytochemistry. Gene expression was quantified via quantitative RT-PCR. 
Additionally, the differentiated cells were tested for their capacity to repair damaged 
sensory epithelium in murine macular organ cultures in vitro. To achieve the overall 
objective, three specific aims were designed: 
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1) To investigate the feasibility of transducing hUCMSCs using adenoviral serotyp s 
5 and 28.  This aim was achieved by infecting hUCMSCs with Ad5 or Ad28 
carrying the green fluorescent protein (GFP) gene. The cells were transduced with 
the vector at varying multiplicities of infection (MOI). It was hypothesized that 
the highest MOI would give the highest transduction efficiency due to the 
availability of a higher number of viral particles infecting per cell. The 
transduction efficiencies between the two serotypes at varying MOIs were 
compared by imaging the intensity of fluorescence and the number of cells that 
fluoresced at days 3, 5 and 10 following transduction. 
2) To assess and compare the ability of hUCMSCs to respond to the Math1 
transcription factor using different promoter types.  This aim consisted of 
transducing hUCMSCs with adenoviral vectors driven by the hCMV promoter 
and the GFAP promoter at the MOI with the highest transduction efficiency in 
Specific Aim 1. It was hypothesized that hUCMSCs would show better Math1 
expression when transduced with the hCMV promoter driven Ad5 vector than 
with the GFAP promoter driven Ad5 and Ad28 vectors.  
3) To induce hair cell differentiation in hUCMSCs in vitro using the Ad5 vector with 
the hCMV promoter and the Math1 gene, and assess the ability of the 
differentiated cells to repair damaged epithelium in murine macular organ 
cultures. This aim consisted of two phases, which were performed in parallel. Th  
first phase consisted of transducing hUCMSCs using the vector with the highest 
Math1 gene expression from Specific Aim 2. In the second phase, the 
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differentiated cells were co-cultured with neomycin-treated murine macular 
organs. It was hypothesized that when transduced, hUCMSCs would differentiate 
into cells that morphologically resemble hair cells and express hair cell and glial 
cell markers. Moreover, it was hypothesized that the differentiated hair cell-like 
cells would repair damaged sensory epithelium in murine macular organs in 
vitro. 
The organization of the remaining chapters is as follows: 
Chapter 2 serves to provide background information in which the literatur  
pertinent to subsequent chapters is reviewed. Also provided in Chapter 2 is a 
discussion of hair cell regeneration, inner ear gene therapy, and use of stem cell-based 
therapies in cochlear repair, highlighting the function of the Math1 gene and its 
homologues in hair cell differentiation, and the importance of curing sensory neural 
hearing loss (SNHL).  
After the background information is established in Chapter 2, Chapters 3 – 6 
address the experiments performed to satisfy the aforementioned Specific Aims. 
Chapter 3 serves to address Specific Aim 1, providing a comparison of transduction 
efficiencies in hUCMSCs between the Ad5 and Ad28 vectors.    
Specific Aim 2 is addressed in Chapter 4. In Chapter 4, the ability of 
hUCMSCs to respond to the Math1 transcription factor using adenoviral vectors 
driven by hCMV promoter and GFAP promoter was assessed. The cells were infected 
at an MOI of 100. Math1 gene expression was analyzed at day 10 post transduction 
by immunostaining the cells with myosin VIIa antibody. 
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Chapter 5 focuses on Specific Aim 3, which involved in vitro inner ear hair 
cell differentiation of hUCMSCs and assessment of the ability of the differentiated 
hair cell-like cells to repair neomycin-treated murine macular organ cultures. The 
transduced cells were characterized morphologically and immunostained with hair 
cell and neuronal markers. Differentiated cells at day 10 were co-cultured with 
neomycin-treated murine macular organs for 10 days and immunostained with 
Myosin VIIa to analyze their ability to repair damaged sensory epithelium. 
Chapter 6 contains the conclusion. Findings from all experiments are 
summarized in a global context and future research directions are discussed. 
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CHAPTER 2: A Review of Gene Delivery and Stem Cell Based Therapies for 
Regenerating Inner Ear Hair Cells 
 
ABSTRACT 
Approximately 49 million Americans suffer from some form of hearing loss 
and almost 47% of the elderly (75 years or older) have sensory neural hearing loss 
(SNHL). Cochlear implants and hearing aids are the only treatments available today. 
Although not life threatening, SNHL isolates an individual from social interactions 
and affects the quality of life. In contrast to these existing treatments, hair cell 
restorations via gene delivery and stem cell-based therapies hold a great potential to 
cure deafness. In this review article, we evaluate some of the advant ges and 
disadvantages of the different viral vectors employed in inner ear g ne therapy and 
the insights gained from the use of embryonic, adult and induced pluripotent stem 
cells in generating inner ear hair cells. 
 
INTRODUCTION 
Hearing loss has become one of the most common disabilities in theUnited 
States and can affect almost every age group. The number of peoplewith hearing loss 
worldwide has been steadily increasing over recent years, reaching almost 49 million 
people in the US alone (1). According to the National Institute on Deafness and Other 
Communication Disorders (NIDCD) 2010 statistics, approximately 17% of the 
American adult population experiences hearing loss and 3 out of every 1000 children 
are born deaf. The prevalence of hearing loss increases with age, as about 47% of 
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adults over 75 years old have hearing impairment (NIDCD). Although hearing loss 
may not be life threatening, it can greatly influence the patient’s quality of life, social 
interactions, and have a significant financial impact on society. (1, 2). 
Hearing loss can be conductive, mixed, central or sensorineural. Conductive 
loss usually occurs due to a block or damage in the outer or middle ear and is most 
often cured surgically or medically (3). In mixed hearing loss, the problem is both in 
the outer or middle and the inner ear. Central hearing loss results from damage to the 
auditory nerves or nuclei of the central nervous system. Sensorineural h aring loss 
(SNHL) involves damage to the cochlea (inner ear sensory hair cells) or the Eighth 
nerve. It is irreversible and in most cases a hearing aid is required. SNHL and 
vestibular dysfunctions account for about 90% of all hearing loss, and they are not 
curable. Common causes for SNHL are aging, ototoxic drugs, noise induced trauma, 
inner ear concussion, and immune disorders (4-6). Although only a small percentage 
of the cases can be treated medically and surgically, advances in molecular and stem 
cell therapies may provide tools to treat the irreparable damage of hair cells caused by 
SNHL (3). 
The ear is of tremendous importance in sensing the world around us. Aside 
from being the prime organ for the perception of sound, it also plays a crucial role in 
balancing the body. The inner ear is a complex structure and has been ref rred to as a 
labyrinth (7). Acoustic energy, in the form of sound waves, is channeled into the ear 
canal where it strikes the tympanic membrane. As the energy hits the stapes located at 
the oval window, a pressure wave sets the cochlear fluid into motion. This results in 
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the depolarization and release of a neurotransmitter from the base of the hair cell.  
Primary auditory afferents then conduct the signal to the brainstem. 
Hair cells are sensory receptors located in the inner ear. They appear to be 
“hair-like” because of the numerous stereocilia that extend from their surfaces. Hair 
cells are responsible for converting sound into electrical signal  th t are sent to the 
brain via the auditory nerve for processing. In the human cochlea, hair cell death can 
occur due to a variety of causes, such as age related deafness (presbycusis), a high 
dosage of ototoxic drugs (e.g., gentamycin, cisplatin, aminoglycosides), g netic 
disorders, infectious diseases, or high levels of noise exposure (7-9). Several 
molecular pathways and mechanisms are involved in hair cell death. Patients exposed 
to high doses of aminoglycosides as a treatment regimen for bacterial infections often 
experience hair cell death. The aminoglycosides are known to activate the 
intracellular caspase-9 signaling pathway and trigger mitochondria to release 
cytochrome c into the cytoplasm, which consequently induces apoptosis in hair cells. 
Noise induced cellular stress activates the JNK signaling pathway and causes 
neuronal cell death via necrosis. Necrotic hair cell death is les common than 
apoptotic cell death and is mainly induced by trauma or disease (7, 9, 10). 
Over the past 30 years, several attempts have been made in the attempt to 
understand the mechanics of the hair cells, molecules, genes and pathways involved 
in hair cell formation and death (11). The process of hair cell regeneration was 
considered impossible to occur in higher vertebrates until two groups (Dr. Rubel and 
Dr. Cotanche) serendipitously discovered the amazing phenomenon in birds in the 
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late 1980s. Ever since, scientists have been conducting experiments in a  attempt to 
understand the mechanics and pathways of avian and mammalian (rat, mouse, guinea 
pig) hair cell regeneration as they have characteristics similar to the human ear (8, 10, 
12-19). An indication of the advancement in the field of hair cell regenration has 
been reported in recent years, and we refer readers to numerous outstanding reviews 
(3, 20-27). This review article will focus on recent therapeutic approaches using stem 
cell biology and gene therapy to regenerate mammalian inner ear hair cells. 
 
HAIR CELLS, SUPPORTING CELLS AND THEIR FUNCTION 
Hair cells 
Hair cells are the mechanoreceptors in the inner ear that detect sound, head 
movements and orientation in space (9, 28). They are present in the sensory 
epithelium of both the auditory (inner and outer hair cells) and vestibular systems 
(Type 1 and Type 2 hair cells). All hair cells are surrounded by supporting cells and 
have physiological and morphological differences. Figure 1 shows the classification 
of inner ear sensory epithelium, and Table 1 gives the differences between an inner 
and outer hair cells.  
Hair cell structure 
Hair cells are flask-shaped cells with extended processes at their apical ends 
called stereocilia. The stereocilia are made of actin filaments and actin bundling 
proteins - fimbrin and espin (29). The vestibular system hair cells have one true 
cilium called the kinocilium that marks the polarity of the cell (Fig. 2). The 
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kinocilium of hair cells in the auditory system degenerate and hence are not 
effectively polarized.  Hair cells form synaptic connections from neurons at the basal 
end and terminate in the cochlear or vestibular nuclei of the brainstem. The term 
“mechanoreceptors” comes from their participation in transforming mechanical 
energy to electrical energy. In the auditory system, the mechanical energy occurs in 
the form of a wave, whereas in the vestibular system, the mechanical energy is a 
result of displacement of hair cells due to the force of gravity or inertia. 
Transduction in Hair Cells 
The stereocilia are connected together by a filamentous tip link. The tips are 
connected to cation transduction channels that are involved in calcium and potassium 
ion exchange. Each hair cell has about 100 transduction channels; the hair cell’s 
mechanical movement and ion exchange control the cell’s membrane potential and 
provide the driving force for auditory or vestibular nerve excitation. Myosin motor 
proteins are activated by the calcium ions and play an important role in triggering the 
hair cell’s adaptation to mechanical stimuli from stereocilia deflections (11). 
 
Supporting Cells 
Supporting cells are the nonsensory cells of the sensory epithelium and do not 
take part in sound transduction. They are located at the base of the hair cells and 
surround them, preventing contact between individual cells. The mammalian auditory 
system has two main types of supporting cells: the Deiter’s cell  support the outer 
hair cells at the base, and the pillar cells help in forming the reticular lamina, which 
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isolates the stereocilia from their cell bodies. A few other supporting cells types 
include interphalangeal cells, Hesen’s cells and Claudius cells (30). Supporting cells 
of the vestibular system have yet to be studied in detail to understand their 
physiological and morphological differences (22, 28). Supporting cellsare known to 
play an important role in avian hair cell regeneration by two different mechanisms: 
mitotic regeneration and transdifferentiation (31). The former occurs when the 
supporting cell divides mitotically, stimulating one of them to differentiate into a hair 
cell, whereas the latter occurs when a supporting cell changes its gene expression and 
becomes a hair cell directly without dividing. 
 
Summary 
 Hair cells reside in the auditory and vestibular systems and are responsible for 
mechanoelectrical transduction of sound. Ototoxic drugs or noise induced stress can 
damage hair cells, thus compromising inner ear function. Supporting cells located at 
the base of the hair cells have the capability to regenerate hair cells in the vestibular 
system by mitotic division or transdifferentiation, though supporting cell proliferation 
may not always occur to replace lost hair cells. 
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ESSENTIAL GENES IN HAIR CELL DIFFERENTIATION 
It is important to identify and characterize genes that govern the ontogeny and 
differentiation of the cochlear epithelium; identifying such genes can lead to the 
design of several therapeutic approaches for sensory epithelial cel  development and 
hair cell differentiation. A critical gene responsible for inner ea  development is the 
Atonal gene - a protein belonging to the basic helix-loop-helix (bHLH) family of 
transcription factors that activates the E-box dependent transcription. Math1, also 
known as Atoh1, is the mouse homolog of the Drosophila melanogaster Atonal gene. 
The Math1 gene is essential for the differentiation of sensory hair cells from 
previously established sensory primordium and is limited to only a subpopulati n of 
the nonsensory supporting cells (32). Studies with embryonic Math1-null mice 
reported a failure to produce hair cells, proving Math1 as a positive regulator in 
directing hair cell differentiation (33). Gene delivery studies in guinea pigs, mice, and 
rats reported an over expression of Math1 in non-sensory cells, resulting in the 
production of ectopic immature hair cells outside the sensory epithelium v a the 
transdifferentiation mechanism (14, 32, 34-38). The nonsensory Math1 expressing 
cells attracted auditory nerve fibers and developed into mature hair cells (35, 36).  
The other homologues of the Atonal gene are Cath1 (chicken atonal 
homolog), Xath1 (Xenopus atonal homolog) and Hath1 (human atonal homolog), 
although Math1 is the most extensively studied and used transcription factor (39, 40). 
Studies with adenoviral expression of Hath1 in rats showed hair cell production 
without supporting cell proliferation (41). 
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Additional genes involved in the control of hair cell fate include Hes1, Hes5, 
BETA2/NeuroD, Jagged1 and Notch Signaling (16, 17). Hes1 and Hes5 have been 
shown to influence cell fate through negative regulation of Math1 (42, 43). Certain 
cell cycle kinases also influence inner ear development by regulating cell cycle and 
inhibiting hair cell differentiation (Refer Table 2.2). BETA2/NeuroD1 gene has been 
shown to regulate the formation of sensory and neuronal ganglions in both cochlear 
and vestibular systems (44). Table 2.2 gives a list of the different genes involved in 
hair cell differentiation. Figure 2.3 represents a schematic on how different genes 
interact and contribute to positive and negative regulation of Math1 transcription 
factor. These pathways can be induced or inhibited via standard or molecular therapy 
and additionally can be used to control the differentiation of stem cells.   
 
GENE THERAPY AND STEM CELL-BASED APPROACHES FOR 
TREATMENT OF SENSORY NEURAL HEARING LOSS 
Current therapies for treating hearing loss involve the use of either hearing 
aids or cochlear implants. Cochlear implants are only available to patients with severe 
hair cell damage and profound loss of hearing ability. However, the implants are not 
absolutely efficient in restoring hearing; their performance varies from patient to 
patient and requires training to adapt to the device. With advances i r generative 
medicine using stem cells and gene therapy, several new strategies have emerged 
with the hope of permanently curing deafness. Some of these strategies are discussed 
in the following paragraphs. 
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Gene therapy in the inner ear 
As discussed earlier, the Math1 gene is an essential gene in generating hair 
cells. Multiple approaches to deliver the Math1 gene into the inner ear have been 
evaluated. Most of the approaches involve the injection of viral or non-viral vectors 
into the inner ear canal to trigger endogenous cells in the organ of corti to 
differentiate. There are a number of other popular routes of vector administration for 
inner ear gene therapy that are well explained in the literature (45-48).  
An ideal vector is one that would ensure patient safety and effective 
transformation of undifferentiated cells. The commonly used vectors are derived from 
adenovirus, adeno-associated virus (AAV), herpes virus and lentivirus. Adenoviral 
mediated Math1 and Hath1 gene delivery has shown promising results in vivo for 
regenerating inner ear hair cells in mammals (14, 34, 35, 37, 49). Adenoviral vectors 
offer high transfection efficiency and have been extensively investigated in clinical 
trials for ocular disease and cystic fibrosis (50, 51). The prior experience with 
adenovectors in the clinic can make them more desirable for commercial and clinical 
applications. The efficacy of adenoviral vectors can be improved by modifying vector 
elements, such as using tissue specific promoters or deleting DNA sequences to 
eliminate production of harmful viral proteins. Adenoviral mediated vestibular hair 
cell regeneration has been reported to be more efficient with the glial fibrillary acidic 
protein (GFAP) promoter than the human cytomegalovirus (hCMV) and chicken β 
actin (cBA) promoters. Additionally, adenovectors with deleted E4 regions resulted in 
increased tolerability of the cells towards the vector (37, 38, 52). In addition to 
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delivering the Math1 gene, adenoviral vectors are used to deliver growth factors such 
as transforming growth factor-β1 (TGF-β1), glial cell-derived neurotrophic factor 
(GDNF), and B-cell lymphoma 2 (Bcl-2) to protect hair cells from sound trauma and 
ototoxic drugs (53, 54). Despite the success of adenoviruses in the effectiv  delivery 
of Math1, short term gene expression and strong immune responses often result, but 
can be overcome by adeno-associated viruses. Studies show the capacity of deno-
associated viruses to deliver genes to inner ear blood vessels and certain auditory 
nerve fibers with negligible toxicity when compared to adenoviruses (48, 55). Herpes 
simplex viral vectors (HSV) derived from Herpes simplex type I can infect and 
replicate in non-dividing cells. Studies in cochlear gene therapy using HSV reported 
dispersed gene expression in the cochlea, limited to auditory and vestibular spiral 
ganglion neurons (56). HSV mediated gene delivery requires the use of high viral 
stock volumes due to the difficulty of producing the vectors in high titers. HSV are 
reported to evoke strong inflammatory responses in guinea pigs (57). Lentivirus is the 
best available viral vector in terms of transduction efficiency and transgene 
expression because of its ability to infect both proliferating and non-proliferating 
cells, including stem cells that are difficult to transduce. Research in lentiviral-
mediated gene delivery in the guinea pig cochlea showed gene expression limited to 
the perilymphatic space in the cochlea. High gene expression was observed in 
ganglion neurons, glial cells, and supporting cells; however, the vector failed to infect 
sensory cells. Although lentiviral vectors offer long term gene expression in a variety 
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of cell types, they are known to have a high risk of evoking a strong immune response 
and generating a replication-competent virus (58). 
Currently, no ideal vector exists for use in inner ear gene delivery. However, 
adenovector based gene therapy is currently the most widely used form of gene 
therapy in the inner ear. Newer recombinant forms of adenoviruses carrying the 
Math1 gene have shown promising results in generating hair cells in both auditory 
and vestibular systems.  Among all known viral vectors, adenovirus is widely 
researched in delivering specific genes (Math1, GDNF, and Bcl-2) for regenerating 
and protecting hair cells. Table 2 lists the advantages and disadvantages of using 
different viral vectors in inner ear gene therapy.  
 The development and use of different viral vectors in inner ear gene th rapy 
allows us to evaluate the effects of introducing specific genes and therapeutic 
molecules that can regenerate hair cells and prevent hair cell damage. 
 
Stem cell-based therapy for inner ear hair cell regeneration 
In the last decade, there has been a considerable amount of attention directed 
toward stem cell-based therapies for treating diseases like Alzheimer’s, Parkinson’s 
and cardiovascular diseases. The success of stem cells in treatg these diseases 
opened opportunities for researchers to explore the use of stem cells in treating 
hearing disabilities. Stem cell therapy is based on the concept that, upon 
transplantation, the undifferentiated stem cell has the capacity to respond and react to 
surrounding cell signals and differentiate into the appropriate cell type associated 
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with the signal. Stem cells are a useful way of exploring the molecular pathways that 
underlie hair cell genesis. Some of the stem cell-based therapeutic stra egies that have 
employed stem cells in the effort to cure hearing loss are listed below. 
Embryonic Stem Cells 
ESCs are pluripotent and capable of giving rise to cells from any of the three 
germ layers (59). With respect to hair cell regeneration, it was reported that murine 
embryonic stem cells can generate inner ear progenitors in vitro (60). These ESCs 
were allowed to form embryoid bodies and were cultured in the presenc  of 
epidermal growth factor (EGF), insulin-like growth factor 1 (IGF-1), and basic 
fibroblast growth factor (bFGF). The newly generated progenitor cells w re reported 
to express markers characteristic of hair cell differentiation and hair cell specific 
markers. Additionally, the progenitor sensory cells had the capacity to ntegrate into 
sensory epithelial layers when injected into the developing inner ear of a chicken and 
to express hair bundle markers in vivo. Another study demonstrated the use of murine 
ESCs from transgenic Math1/nGFP mice (61). The ESCs were differentiated using a 
step-by-step method toward the ectodermal lineage using otic-inducing growth 
factors. The generated otic progenitor cells had the capacity to develop into 
mechanosensitive sensory hair cells in vitro and demonstrated immature hair cell 
transduction currents (61). ESCs have been reported to produce sensory auditory 
neurons and neural progenitors with the potential to restore auditory function by 
generating nerve connections to hair cells (62-64). Embryoid bodies from murine 
ESCs co-cultured with hair cell explants showed neuron-like cells and positive 
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staining for neurofilament(63). Most of the embryonic stem cell studies have used 
murine stem cells; however, there have been attempts to differentiate human 
embryonic stem cells (hESCs) in the presence of growth factors like neurotrophin-3 
(NT-3), bFGF, BDNF, EGF and bone morphogenic protein 4 (BMP4). The 
differentiated cells expressed inner ear and synaptic markers (65-67). hESCs have 
also been cultured to generate otic progenitors that were capable of differentiating 
into auditory sensory neurons (66).  
Although these studies have demonstrated successful in vitro and in vivo 
generation of replacement hair cells and auditory neurons from ESCs, further 
investigations are crucial in developing treatment strategies for hearing loss because 
of the controversial and ethical issues linked to ESCs. 
 
Adult Stem Cells 
Promising results have been shown with bone marrow mesenchymal stem 
cells (BMSCs) in the field of hair cell regeneration. Mesenchymal stem cells derived 
from rat bone marrow have been reported to differentiate into inner ear progenitors 
and express sensory cell markers including myosin VIIa, espin, Brn3c, p27kip and 
jagged2 in vitro (68). Additionally, the differentiated cells displayed morphological 
characteristics of hair cell stereociliary bundles. Studies have shown that BMSCs 
stimulated in the presence of growth factors were able to form neuro al progenitors, 
and after being transfected with the Math1 gene, were able to differentiate into inner 
ear sensory-like cells (68). Adult stem cells also have the potential to deliver gene and 
therapeutic molecules to other parts of the inner ear. For example, Connexin 26, a 
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protein present in cochlear gap junctions and supporting cells was expressed when 
bone marrow stromal cells were transplanted into the perilymphatic space of the 
mouse cochlea. (69). Bone marrow mesenchymal stem cells also have the potential to 
differentiate into auditory neurons in vitro and in vivo (70, 71), demonstrating that a 
wide variety of inner ear cell types can be generated from stem cells. 
Adult stem cells isolated from mouse macular organs have been shown to 
differentiate into hair cells when cultured with EFG and IGF-1 (72). Adult stem cells 
isolated from olfactory neuroepithelium expressed hair cell markers and resembled 
hair cells phenotypically when co-cultured with cochlear cell supernatant (73). 
Transplantation studies in mice with bone marrow-derived hematopoietic stem 
cells (BMHSCs) suggested the possibility of differentiation of BMHSCs into 
mesenchymal cells and fibrocytes in the adult inner ear (74). The results with 
BMHSCs show their potential to attenuate cochlear injury by replacing mesenchymal 
cells and fibrocytes in the inner ear (74). 
Adult stem cells from many tissues are now being used to investigate cures for 
various diseases. They are less controversial when compared to embryonic stem cells. 
These cells can enter clinical trials involving autologous transpltation therapies and 
be used in bioengineered products. In treating inner ear disorders, bone marrow-
derived stem cells have shown the most favorable results (69, 70, 74, 75). 
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Induced Pluripotent Stem Cells 
The discovery of generating induced pluripotent stem cells (iPSCs) gave a 
new dimension to stem cell research. iPSCs are produced from adult stem cells, 
which are reprogrammed to express certain genes and maintain ch racteristic 
properties of embryonic stem cells. iPSCs opened up the possibility of generating and 
using patient-specific stem cells without immune rejection in vivo and, unlike hESCs, 
there are no controversial issues associated with their use. The most important factors 
in maintaining the pluripotency of ESC lines are Oct4, c-Myc, Klf4 and Sox2. Any 
adult stem cells forced to express the above four genes under ESC culture onditions 
can be reprogrammed into ESC-like cells (76). Recently, it was demonstrated that 
human neural stem cells can be directly reprogrammed to iPSCs by just expressing 
Oct4 (77). Like ESCs, most studies with iPSCs in hair cell regeneration are also of 
murine origin. A recent study showed generation of iPSCs from murine embryonic 
fibroblasts (61). These fibroblasts were transduced with retroviruses to express Oct4, 
c-Myc, Klf4 and Sox2. The generated iPSCs were cultured in a medium containing 
otic-inducing FGF-3 and FGF-10 to produce otic progenitor cells. The gen rat d otic 
progenitors differentiated into hair cell-like cells expressing hair cell markers. When 
co-cultured with fibroblast-like cells from embryonic chicken utricles, the 
differentiated cells developed hair bundle-like protrusions, responded to mechanical 
stimulation, and displayed transduction currents (61). Another study explored the use 
of iPSCs for restoring auditory ganglion neurons. In vitro neuronal differentiation of 
iPSCs was induced by exposing them to stromal cell-derived inducing activity 
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(SDIA). SDIA is a neural inducing activity demonstrated in stromal cells when they 
simultaneously produce inducing and inhibitory factors and was developed by 
Kawasaki et al. (78). The differentiated cells were transplanted into the cochleas of 
mice. iPS cell-derived neurons projecting toward cochlear hair cells w re observed 1 
week after transplantation (79). Although iPS cell techniques are nov l, researchers 
have started to explore their potential in treating SNHL. 
Stem cell therapy holds great promise for curing SNHL; however, th e has 
been little progress to that end. Some of the barriers that exist with he use of stem 
cells are the formation of tumors and graft-versus-host disease . Owing to the spiral 
structure of the cochlea, it is difficult to direct the stem cells into the desired location 
inside the cochlea. Additionally, the inner ear fluids are rich in potassium ions, 
providing a challenging environment for the stem cells to differentiate (24). Further 
investigation with the use of different stem cell types and advancements in the 
existing approaches are necessary before they can enter the clinical and begin treating 
hearing disorders.  
Summary of Stem Cell-Based Therapies  
ESCs have high survival rates and migration capacity when implanted into the 
cochlea (80, 81). They migrated onto auditory neurons and exhibited neuronal 
differentiation. However, ESCs exhibited low integration into endogenous tissue and 
failed to differentiate completely at the implantation site (82, 83). There is also the 
risk of tumor formation and the risk of transmitting infections with ESCs because 
they use animal products during the culturing process. ESCs used in inner ear 
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treatment require the use of immunosuppressive therapy or cloning to avoid graft-vs-
host diseases. On the other hand, adult stem cells isolated from bone marrow can 
easily bypass the immune barriers and overcome the problem of immune rejection. 
BMSCs also have a high survival rate and can migrate into multiple regions in the 
cochlea and brain (70, 84-86). Although they can be stimulated to differentiate into a 
number of cell lineages, they differentiate more toward the mesoderm lineage and can 
be used to replace degenerated cochlear fibrocytes (87). iPSCs do not have any 
ethical concerns with their use and are more patient specific, thus eliminating the risk 
of immune rejection. Their undifferentiated state allows them to migrate to regions 
surrounding the cochlea. However, one of the major concerns with iPSCs s the time 
required to produce the individual cell lines (88). They also pose the risk of passing 
on the DNA from the genetically altered cell to future generations.   
Some of the barriers that exist with the use of stem cells are the formation of 
tumors and graft-versus-host diseases. Another concern is the integration of stem cells 
in the inner ear. Owing to the spiral structure of the cochlea, it is challenging to direct 
the stem cells into the desired location and evaluate the integration of differentiated 
stem cells inside the cochlea. Further investigation with the use of different stem cell 
types and advancements in the existing approaches are necessary before they can 
enter the clinic and begin treating hearing disorders.  
Nevertheless, these concerns bring opportunities for bioengineers and 
clinicians to engineer cells and vectors carrying a combination of genes and 
therapeutics and develop methods and devices to deliver therapeutics at appropriate 
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locations.  Recent advances in stem cell technology and gene based therapies provide 
the framework required for the development of potential treatment options. 
 
DISCUSSION 
The success of current approaches unveils the possibility of using different 
viral vectors, genes, growth factors and stem cell types in regenerating inner ear hair 
cells. Nevertheless, more research is still required to overcom challenges involved 
before these approaches will be ready for clinical and commercial use. Although 
several studies have reported the generation of hair cell-like cells in vitro and in vivo 
(in animals), the outcome and characteristic properties of these cell  must be further 
explored. A cell that simply resembles a hair cell morphologically and expresses hair 
cell markers would be immature without being able to respond to mechanical stimuli 
and transfer signals to the auditory neurons. A detailed investigation of their ultra 
structure and ability to connect to auditory neurons and produce transduction currents 
is essential. In terms of functional outcomes, crucial to any tissue engineering 
strategy, the mechanoelectrical transduction and maturity of transplanted hair cell-like 
cells can be evaluated by auditory brainstem response (ABR) and otoacoustic 
emissions tests (OAE) in animal studies. 
Audiologists and scientists have come a long way toward reaching the goal for 
hair cell regeneration in mammals by developing inner ear gene th rapy strategies in 
animal models. However, an improvement in the existing gene delivery techniques is 
required to suit clinical applications.  
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Some of the drawbacks associated with inner ear gene therapy are addressed 
below. For example, gene delivery studies have shown  that over-expression of the 
Math1 gene led to the formation of ectopic hair cells (14, 36). Hair cells are 
extremely rare and the cochlea contains only about 14,000 hair cells that detect and 
amplify sound (67), therefore an overabundance of hair cells in the cochlea can also 
lead to deafness. There are several pathways that control the expression of Math1 and 
drive a cell toward differentiating into a hair cell. Math1 inhibitors and down 
regulators can be used in addition to targeting the inner ear with only the Math1 gene. 
This approach can be used to produce an appropriate number of hair cells. Th  
activation of a notch receptor can up regulate Hes and Hey genes that are potent 
inhibitors of Math1 (16, 17, 43). Inclusion of notch receptor inhibitors in gene therapy 
can help in boosting Math1 gene expression. However, a balance of expression and 
inhibition between the Math1 gene and Math1 inhibitor is required for normal inner 
ear development and hearing. 
Besides developing strategies to control the expression of the Math1 gene, the 
side effects caused by viral routes also need to be considered. Although viral methods 
have shown tremendous success in the animal model, there is alway  the risk of DNA 
mutations and cancer associated with viruses. Non-viral gene delivery techniques 
have recently gained attention due to the minimal risks associated in t rms of clinical 
safety and reliability. Another drawback of Math1 gene therapy is that although it can 
be a potential cure for hearing loss caused by sound trauma or ototoxic damage, it 
may not cure hearing loss caused by genetic defects. Stem cell-based therapies in vivo 
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have reported migration of these cells into different areas, and thus an ideal route for 
delivering cells to the right location in the cochlea is crucial to restoring hearing loss. 
The large majority of studies have used only animal models and animal stem cells. 
There is no doubt that these studies have played a major role in gathering valuable 
information about hair cell regeneration; however, the variation among species 
requires the need to explore the use of human stem cell lines like bon  marrow 
derived mesenchymal and hematopoietic stem cells, umbilical cord bl od and 
umbilical mesenchymal stromal stem cells, and induced pluripotent sm cells. 
Research in human stem cells lines will have more clinical relevance. 
Gene delivery and stem cells are a potential cure to hearing loss however, 
there are limitations that must be overcome. Gene therapies must con ider using 
combinations of essential genes and cell cycle inhibitors to control the production of 
hair cells, and detailed quantification of hair cell functionality is necessary. Gene 
delivery vehicles with minimal risk of mutagenesis and immune response must also 
be developed. Finally, an ideal route to implant stem cells inside the cochlea would be 
essential for successful innervations of hair cells, thereby allowing better, if not 
pristine transmission of sound with the assistance of a cochlear implant. 
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CHAPTER 3: Comparison of Transduction Efficiency in Human Umbilical 
Cord Mesenchymal Stromal Cells between Adenovirus Serotypes 5 and 28 
 
ABSTRACT 
Adenoviruses are among the first known vectors that are capable of infecting 
both proliferating and non-proliferating cells. They are one of the most effective 
expression systems and occur in several different serotypes. However, the entry of an 
adenovirus largely depends on the binding of virus fiber protein and the host cell 
surface receptor. Ad5 vectors rely on coxsackie adenovirus receptor (CAR) and other 
integrin related receptors to integrate into the cell’s genome. Human umbilical cord 
mesenchymal stromal cells (hUCMSCs) are derived from Wharton’s jelly between 
the blood vessels of the umbilical cord. Since hUCMSCs do not express CAR,
protamine sulfate (a polycationic peptide) was used to increase viral adsorption.  In 
this study, we investigated the feasibility of transducing hUCMSCs using Ad5 
(Adf11D) and Ad28 (Ad28t.eGFP) green fluorescent protein (GFP) vectors using 
protamine sulfate as a cross-linking agent and compared the transduction efficiencies 
between the two serotypes. The results suggest that both Ad5 and Ad 28 can 
effectively transduce hUCMSCs, however Ad28 achieved higher gene expr ssion and 
transduction efficiency.  
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INTRODUCTION  
Gene delivery is emerging as a promising approach in the medical and 
pharmaceutical field. Gene therapy is defined as the transfer of new genetic material 
or therapeutic molecules into a cell to alter its function at the cellular or molecular 
level for therapeutic applications (89). The future of gene therapy largely depends on 
designing vectors that are capable of effectively delivering therapeutic molecules and 
genes to target cells with minimal cytotoxic effects (90). Recombinant adenoviral 
vectors were first used to deliver genes in the treatment of cystic fibrosis (91). They 
are now used in several in vitro and in vivo experiments due to their remarkable 
potential of infecting both dormant and dividing cells (92, 93). 
The human adenoviruses are among the largest double stranded and most 
complex non-enveloped viruses. These viruses have 11 different structural proteins 
and occur in more than 50 serotypes (91, 94). Owing to their complex structure, their 
cell entry pathway involves several complex steps. The initial s ep is the binding 
between the fiber knob domain and the host cell receptor (CAR or CD46). This is 
followed by the secondary internalization between the RGD penton base and the αυ 
integrins. The secondary interaction enables entry via clathrin mediated endocytosis. 
Once the virion enters the cells, it begins to dissemble and is tran ported to the 
nuclear pore complex by microtubule trafficking. At the nuclear pore, the viral DNA 
enters the host cell nucleus (90, 94). From these steps, it is evident that the binding of 
the virus to the host cell receptor is the most crucial step in gene transfer and 
adenoviral mediated gene transfer is limited in most cell types du  to the absence of 
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adenoviral receptors. Many cell types, including hematopoietic stemcells and bone 
marrow mesenchymal stem cells, lack the adenoviral receptors and are not easily 
infected by Ad5 vectors (95, 96). Native Ad5 based vectors are wild type vectors and 
have successfully transduced cells expressing CAR and other cell surface integrin 
receptors (90, 97, 98). A strategy to effectively infect cells without CAR is to use 
fiber modified vectors (99-102) or to transduce cells with the virus at a high 
multiplicity of infection (MOI). However, high MOI levels produce high 
inflammatory responses in host cells, which is undesirable in clinical use. 
hUCMSCs are isolated from Wharton’s jelly of umbilical cords and have 
some properties in common with bone marrow mesenchymal stem cells (BMSCs) 
(103). Umbilical cords represent an abundant and inexpensive cell source. hUCMSCs 
can differentiate into a number of cell types and offer significant potential in gene 
delivery techniques (104-107). Although some studies have investigated the 
transduction of BMSCs (108, 109), there have been few reports on the transduction of 
hUCMSCs. Qian et al. (107) reported lentiviral mediated gene delivery in hUCMSCs 
and Rachakatla et al. (106) reported adenoviral transduction of hUCMSCs using a 
recombinant fiber-modified adenovector. 
In this study, hUCMSCs were transduced using two different adenoviral 
serotype vectors - Ad5 and Ad28 - at varying multiplicities of infections (MOI) in the 
presence of protamine sulfate as a cross linking agent. Protamine sulfate is a 
polycation that increases transduction efficiency by enhancing viral uptake (110, 
111). We compared the transduction efficiencies in hUCMSCs by fluorescence 
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imaging of green fluorescent protein (GFP) at days 3, 5 and 10. We determined which 
vector and which MOI transduced the maximum number of cells with a high intensity 
of fluorescence and maximum gene expression.  
 
MATERIALS AND METHODS 
Isolation and expansion of hUCMSCs  
hUCMSCs were isolated from human umbilical cords according to protocols 
approved by the University of Kansas Human Subjects Committee (KU-Lawrence 
IRB approval # 15402, KU Medical Center IRB approval # 10951). The cords were 
obtained from the hospital and harvested within 24 hours after delivery. The cords 
were rinsed in phosphate buffered saline (PBS) and cut into small pieces of 2 to 3 cm. 
The vascular tissue was then removed, and the cords were minced and incubated in 
0.2% type II collagenase (298 U/mg; Worthington Biochemical; Lakewood, NJ) in 
low glucose Dulbecco’s modified Eagle’s medium (DMEM) for 4 hours at 37°C on a 
shaker. The digested homogenous solution was diluted in sterile PBS at a 1:4 ratio 
and centrifuged for 5 minutes at 1100 rpm. The supernatant was discarded nd the 
cells frozen for future use. Frozen hUCMSCs were thawed, plated at a density of 
7,000 cells/cm2, and cultured in low glucose DMEM with 10% fetal bovine serum 
(FBS-MSC quantified) and 1% penicillin/streptomycin (Invitrogen Life 
Technologies, Carlsbad, CA). Cells were fed every 2 days and maintained in a cell 
culture incubator at 37°C. At 80 - 90% confluency, the cells were trypsinized and 
passaged. hUCMSCs were isolated from 4 different human umbilical cords (n = 4)
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and expanded to passage 4 (P4) for the experiments. All experiments were performed 
in quadruplicate for each cord. 
 
Adenoviral vectors and vector production 
Ad5 and Ad28 serotypes were used in this study. The Ad5 (Adf11D) vector 
backbone had E1, E3, and E4 regions deleted. The production system for the vector 
provided robust replication of the adenovector and purified stocks at 5 x 1011 and 2 x 
1012 total particle units/ml (pu/ml), with a total particle to particle ratio ranging from 
3 to 10 pu/fluorescent focus units. The Ad28 (Ad28t.eGFP) vector backbone had E1 
region deleted with the transgene expression cassette inserted at the E1 region. They 
were produced using 293-ORF cells. The production system for the vector provided 
robust replication of the adenovector and purified stock at 3 x 1012 fluorescent focus 
units/ml. The total particle units were determined by a spectrophotometric assay that 
has been standardized and qualified to reliably and robustly quantify the to al 
particles within a single lot of adenovector. The adenovector lots were pu ified, 
aliquoted and stored at -80°C. Individual aliquots were used for each experiment to 
prevent loss of activity associated with freeze-thaw cycles. Both vectors had their 
transgene (GFP) expression driven by the hCMV promoter, and the expression 
cassette contained an open reading frame and an SV40 polyadenylation site and 
transcriptional stop site at the 3’ end of the open reading frame (GenVec Inc., 
Gaithersburg, Md., USA) (54, 112). 
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Adenoviral transduction of hUCMSCs 
hUCMSCs were trypsinized at P4 and the cells were plated in 48-wells at 
1,000 cells/well (n=4) and 500 µl hUCMSC medium (low glucose DMEM, 10% FBS, 
1% penicillin/streptomycin) was added per well. Cells were allowed to attach for 24h 
before the virus was added directly to the medium at 10, 50, and 100 multiplicities of 
infection (MOI) in the presence of 8 µg/ml of protamine sulfate (MP Biomedicals, 
Irvine, CA) (107, 113). Controls had all the above components but the vector. The 
plate was gently rocked after adding the vector and incubated at 37°C. The medium 
was changed after 24h and every 48h for the remaining culture period. The cells were 
cultured for 10 days and transient gene expression was imaged using a fluorescent 
microscope at days 3, 5 and 10. 
 
Fluorescent imaging of transduced cells  
Transient gene expression at days 3 and 5 was imaged.  At ay 10, the cells 
were fixed for 10 minutes in 4% paraformaldehyde in PBS, followed by washing the 
cells three times in PBS. The cells were then stained using ProLong Gold antifade 
with DAPI (4', 6-diamidino-2-phenylindole) (Invitrogen Life Technologies, Carlsbad, 
CA) and imaged. DAPI strongly binds to A-T rich regions in the DNA and stains the 
cell nuclei. Microscopic images of eGFP-positive cells were acquired using an 
inverted fluorescent microscope (Nikon Eclipse E2000-U, Melville, NY), QImaging 
Retiga 2000R camera and QCapture software. 
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RESULTS 
Effects of transducing hUCMSCs at different MOIs with Ad5 and Ad28 
serotypes 
 By visual examination, it was observed that the intensity of fluorescence and 
the number of cells transduced with both vectors gradually increased from MOI 10 – 
100. No fluorescence was observed in the controls. To investigate the ransduction 
efficiencies and the transient GFP gene expression between Ad5 an  Ad28 in 
hUCMSCs, the transgene gene expression was imaged at days 3, 5 and 10 (Figures 
3.1 – 3.2). With both vectors, the maximum number of GFP expressing cells was 
observed at MOI 100. The cells had maximum fluorescence intensity and 
transduction efficiency at day 5, with gene expression fading off by day 10. However, 
when the gene expression between both vectors was compared, Ad28 had a higher 
number of GFP expressing cells and higher fluorescence intensity at all MOIs on all 
days when compared to Ad5. The results suggest that the Ad28 vector gave better 
transduction efficiency when compared to the Ad5 vector. 
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DISCUSSION 
Adenovectors are the best known vectors for transducing both dividing and 
non dividing cell types. It has great potential in clinical applications. One of the major 
drawbacks of an adenoviral vector reported in several studies is it  poor ability to 
infect cells lacking adenoviral receptors. Adenoviruses depend on cell surfaces for 
internalization and endocytosis (97, 114). hUCMSCs also lack the coxsackie 
adenoviral receptor (106). There are several approaches to improve adenoviral 
transduction efficiency in human stem cells and overcome gene transfe  issues 
associated with CAR dependent entry of the adenovirus. Use of lipofectamine has 
been reported to improve the transduction efficiency of human hematopoietic stem 
cells (115). Lactoferrin can be used as a bridge to enhance binding between the host 
cell and the virus to increase transduction efficiency (116). Increasing the viral 
concentration can increase efficiency, however, this can be toxic to the cells and 
cause an inflammatory response (117, 118). Viral adsorption and uptake can be 
enhanced using polycations like polybrene, protamine sulfate, and polylysine (119).
The positively charged polycationic molecules mask the negative charges on the host 
cell surface and increase the availability of cell surface rec ptors. The viral vectors 
can be complexed with the polycations and enter the cells via endocytosis (110, 120).  
In this study, we characterized the feasibility of transducing hUCMSCs using 
Ad5 and Ad28 vectors and compared the transduction efficiencies between he two 
serotypes. Overall, Ad28 was observed to transduce hUCMSCs better than Ad5 in 
terms of both the intensity of fluorescence and the number of cells tran duced. Both 
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vectors showed transgene expression at all MOIs, with MOI 100 giving the best gene 
expression. The cells were imaged at days 3, 5 and 10 to evaluate the transi nt gene 
expression in both vectors. Gene expression reached a maximum level on day 5 and 
gradually declined by day 10.    
The use of protamine sulfate as a cross linking agent may have enhanc d the 
uptake of adenoviral particles and contributed to improving the transduction 
efficiency in both the Ad5 and Ad28 vectors (111, 121). Lentiviral transduction of 
hUCMSCs has used polybrene as a cross linking agent to enhance efficiency (107). 
However, preliminary studies of adenoviral transduction in hUCMSCs with 
polybrene indicated cytotoxicity and cell death. Protamine sulfate is another 
polycation reported to be an excellent alternative to polybrene (113). Studies with 
protamine sulfate have demonstrated essentially the same infectio  efficiency as 
polybrene with low cytotoxicity on a range of cell types (113) and therefore was used 
as an alternative to polybrene. 
 
CONCLUSIONS 
In this study, the feasibility of transducing hUCMSCs using an adenoviral 
vector in the presence of protamine sulfate was demonstrated, and a multiplicity of 
infection of 100 was found to produce the best level of gene delivery in both Ad5 and 
Ad28 vectors, with Ad28 significantly outperforming Ad5.  
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CHAPTER 4: Ability of Human Umbilical Cord Mesenchymal Stromal Cells to 
Respond to Math1 Transcription Factor via Adenoviral Mediated Gene Transfer 
Using Different Promoter Types 
 
ABSTRACT 
Gene delivery to human umbilical cord mesenchymal stromal cells 
(hUCMSCs) has vast potential in gene therapy-based treatment strategies, and 
adenoviruses are currently used in several clinical trials. Adenoviruses have been 
widely used in targeting several inner ear cell types to deliver the Math1 gene. Math1 
is a critical gene responsible for the differentiation of sensory hair cells. In this study, 
we investigated the ability of hUCMSCs to respond to the Math1 transcription factor 
driven by the hCMV and GFAP promoters. We demonstrated a relatively higher 
number of myosin VIIa positive and hair cell-like cells in hUCMSCs infected with a 
vector driven by the hCMV promoter. The potential of hUCMSCs to express Math1 
suggests the possibility of inducing hair cell differentiation in vitro. 
 
INTRODUCTION 
Human umbilical cord mesenchymal stromal cells (hUCMSCs) are beli ved 
to be multipotent stem cells, and have shown promising results in gene delivery and 
tissue engineering applications (106, 122). These cells can be an excellent source for 
cell transplantation therapies and regenerative medicine because of their low immune 
rejection and non tumorigenic properties (123). However, to make any stem cell 
useful in clinical applications, it must be differentiated into a specific cell type. 
Differentiation can be achieved by delivering growth factors in several ways. One 
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approach is to use a viral vector to deliver a specific gene of interest. In this study, we 
tested the ability of hUCMSCs to respond to the Math1 gene. Math1 is a protein 
belonging to the basic helix-loop helix family of transcription factors. It is expressed 
in inner ear hair cells and neural cells in the hindbrain, spinal cord and germinal layer 
of the cerebellum (33). Studies have reported that Math1-null mice failed to produce 
inner ear hair cells and overexpression of Math1 led to the production of numerous 
ectopic hair cells in mice (33, 36). The Math1 gene therefore plays a key role in the 
formation of inner ear hair cells.  
In the past, several viral vectors have been used to deliver the Math1 gene in 
the inner ear to regenerate hair cells, however, the most promising results were 
obtained with adenoviral vectors at high transduction efficiencies and with low 
cytotoxic effects (35, 49, 54). Studies have shown transgene expression for up to 3 
weeks in the inner ear with adenoviral vectors (49). Another essential property of 
vectors that plays an important role in transgene expression is the promoter used in 
constructing these vectors (52). In this study, we assessed the ability of hUCMSCs to 
express Math1 driven by two different promoter types – human cytomegalovirus 
(hCMV) and glial fibrillary acidic protein (GFAP) promoters. Our further 
experiments to induce hair cell differentiation in hUCMSCs via adenoviral mediated 
gene delivery used results obtained from this study and transduced cells using 
AdMath1.11D. 
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MATERIALS AND METHODS 
Isolation and expansion of hUCMSCs  
hUCMSCs were isolated from human umbilical cords according to protocols 
approved by the University of Kansas Human Subjects Committee (KU-Lawrence 
IRB approval # 15402, KU Medical Center IRB approval # 10951). The cords were 
obtained from the hospital and harvested within 24 hours after delivery. The cords 
were rinsed in phosphate buffered saline (PBS) and cut into small pieces of 2 to 3 cm. 
The vascular tissue was then removed, and the cords were minced and incubated in 
0.2% type II collagenase (298 U/mg; Worthington Biochemical; Lakewood, NJ) in 
low glucose Dulbecco’s modified Eagle’s medium (DMEM) for 4 hours at 37°C on a 
shaker. The digested homogenous solution was diluted in sterile PBS at a 1:4 ratio 
and centrifuged for 5 minutes at 1100 rpm. The supernatant was discarded nd the 
cells frozen for future use. Frozen hUCMSCs were thawed, plated at a density of 
7,000 cells/cm2, and cultured in low glucose DMEM with 10% fetal bovine serum 
(FBS-MSC quantified) and 1% penicillin/streptomycin (Invitrogen Life 
Technologies, Carlsbad, CA). Cells were fed every 2 days and maintained in a cell 
culture incubator at 37°C. At 80 - 90% confluency, the cells were trypsinized and 
passaged. hUCMSCs were isolated from 4 different human umbilical cords (n = 4)
and expanded to passage 4 (P4) for the experiments. All experiments were performed 
in quadruplicate for each cord. 
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Adenoviral vectors and vector production 
The Ad5 vectors (AdMath1.11D and Ad5.GFAP.Math1) had E1, E3 and E4 
regions deleted with an expression cassette of Math1 driven by the human 
cytomegalovirus (hCMV) and human glial fibrillary acidic protein (GFAP) promoters 
respectively. The production system for the vector provided robust replication of the 
adenovector and purified stocks at 5 x 1011 and 2 x 1012 total particle units/ml 
(pu/ml), with a total particle to particle ratio ranging from 3 to 10 pu/fluorescent 
focus units. The Ad28 (Ad28.GFAP.Atoh1) vector backbone had E1 region deleted 
with an expression cassette of Atoh1 driven by the GFAP promoter. The 
Ad28.GFAP.Atoh1 vector particles were produced using 293-ORF cells. The 
production system for the vector provided robust replication of the adenovector and 
purified stocks at 5 x 1011 and 2 x 1012 total pu/ml, with a total particle to particle 
ratio ranging from 3 to 10 pu/fluorescent focus units. The total particle units were 
determined by a spectrophotometric assay that has been standardize  and qualified to 
reliably and robustly quantify the total particles within a single lot of adenovector. 
The adenovector lots were purified, aliquoted and stored at -80°C. Individual aliquots 
were used for each experiment to prevent loss of activity associated with freeze-thaw 
cycles. The expression cassette contained an open reading frame and an SV40 
polyadenylation site and transcriptional stop site at the 3’ end of the open reading 
frame (GenVec Inc., Gaithersburg, Md., USA) as previously described (38, 112). 
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Adenoviral transduction of hUCMSCs 
hUCMSCs were trypsinized at P4 and the cells were plated in 8 well Millicell 
EZ Slide (Millipore, Billerica, MA) at 1,000 cells/well (n=4) and 500 µl hUCMSCs 
medium (low glucose DMEM, 10% FBS, 1% penicillin/streptomycin) wasadded per 
well. Cells were allowed to attach for 24 hours before the virus was added directly to 
the medium at a multiplicity of infection (MOI) of 100 in the presence of 8 µg/ml of 
protamine sulfate (MP Biomedicals, Irvine, CA) (107, 113). Controls did not have 
any vector added. The chamber slide was gently rocked after adding the vector and 
incubated at 37°C. The medium was changed after 24h and every 48h for the 
remaining culture period. The cells were cultured for 10 days and immunostained for 
myosin VIIa.   
 
Immunocytochemistry 
Cells were fixed for 10 minutes with 4% paraformaldehyde in PBS. This was 
followed by washing three times in PBS. Immunostaining was initiated by blocking 
the slides for 1 hour with 5% FBS, followed by four 0.2% Tween washes. The cells 
were then permeabilized with 0.2% Triton X-100 for 10 minutes. Myosin VIIa 
positive expression was characterized using polyclonal antibody to myosin VIIa. 
Fixed and permeabilized cells were incubated at 4°C overnight with the primary 
antibody (1:100). The primary antibody used was a rabbit polyclonal antibody to 
Myosin VIIa (Proteus Biosciences, Ramona, CA). Slides were then washed four times 
with 0.2% Tween and incubated with secondary antibody (1:400) for 30 minutes at 
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room temperature. The secondary antibody with Alexa visualizing fluorescent signals 
used was Alexa-555-conjugated goat anti-rabbit IgG (Molecular Probes, Eugene, 
OR). All incubations were in a humidified chamber. Incubation was followed by four 
washes with 0.2% Tween. The slides were mounted in ProLong Gold antifade with 
DAPI (4',6-diamidino-2-phenylindole) (Invitrogen Life Technologies, Carlsbad, CA) 
and cover slipped. DAPI strongly binds to A-T rich regions in the DNA and stains the 
cell nuclei blue. Microscopic images of myosin VIIa-positive cells counterstained 
with DAPI were acquired using an upright fluorescent microscope (Nikon Eclipse 
E800 and Q Image Aqua camera) and QCapture software. Images were photomerged 
and analyzed with Adobe Photoshop CS5 extended (Adobe Systems, San Jose, CA). 
 
RESULTS 
Myosin positive cells from human umbilical cord mesenchymal stromal cells 
To examine the potential of hUCMSCs to respond to Math1, hUCMSCs were 
transduced with the AdMath1.11D vector driven by the hCMV promoter and the 
Ad5GFAP.Math1 and the Ad28.GFAP.Atoh1 vectors driven by the GFAP promoter 
at a multiplicity of infection of 100.  
We detected the expression of the myosin VIIa marker in hUCMSCs 
transduced with all three vectors. Only a small percentage of c lls expressed myosin 
VIIa. However, the AdMath1.1D vector driven by the hCMV promoter had a 
relatively higher number of myosin VIIa positive cells when compared to 
Ad5.GFAP.Math1 and Ad28.GFAP.Atoh1 vectors that were driven by the GFAP 
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promoter. The positive cells in AdMath11D transduced cells also demonstrated a 
degree of anatomical resemblance to hair cells (Figures 4.1 – 4.3). 
 
DISCUSSION 
This study tested the potential of hUCMSCs to respond to the Math1 
transcription factor driven by two different promoter types – hCMV and GFAP. In 
preliminary studies, we demonstrated the expression of the Math1 gene by 
immunostaining with a polyclonal antibody to Atoh1 (Aviva Systems Biology, San 
Diego, CA). Here, we showed that hUCMSCs are capable of expressing the Math1 
gene by immunostaining with rabbit polyclonal to myosin VIIa antibody. Since the 
Math1 gene is essential for hair cell formation, hUCMSCs expressing Math1 should 
stain positive for myosin VIIa (33). In this study, AdMath1.11D demonstrated  
higher number of myosin VIIa positive cells when compared to the Ad5.GFAP.Math1 
and Ad28.GFAP.Atoh1 vectors. Controls also expressed a certain level of myosin 
VIIa positive cells, however, the expression was minimal when compared to the 
vector treated cells and there were no cells morphologically resembling hair cells. 
Previous studies using adenoviruses or adeno-associated viruses for inner ear g ne 
delivery in the cochlea using the CMV and GFAP promoters demonstrated that the 
expression driven by the GFAP promoter was limited only to vestibular s pporting 
cells, demonstrating the specificity of this promoter type (52, 124). These previous 
findings explain the low gene expression in hUCMSCs with the transgene cassette 
driven by the GFAP promoter.  
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CONCLUSIONS 
Previously, the Math1 gene has been shown to express in rat and mouse bone 
marrow mesenchymal stem cells when transfected using Lipofectamine (68, 125). 
However, there have been no reports on viral gene delivery of the Math1 gene in 
mesenchymal stem cells. In this study, the ability of hUCMSs to respond to the 
Math1 transcription factor using an adenoviral vector was demonstrated by the 
presence of myosin VIIa positive cells. We demonstrated for the first time that 
mesenchymal stem cells can respond to the Math1 transcription factor delivered using 
a viral vector. The AdMath1.11D vector was shown to produce a relatively higher 
number of myosin VIIa positive cells when compared to the Ad5.GFAP.Math1 and 
Ad28.GFAP.Atoh1 vectors.  
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CHAPTER 5: Adenoviral Mediated Gene Delivery to Human Umbilical Cord 
Mesenchymal Stromal Cells for Inner Ear  
Hair Cell Differentiation 
 
ABSTRACT 
Stem cells in the inner ear lack the capacity to spontaneously divide and 
replace lost or damaged hair cells. Human umbilical cord mesenchymal stromal cells 
(hUCMSCs) have been reported to differentiate into several cell lin ages including 
bone, cartilage, and neurons and therefore may have the potential to differentiate into 
inner ear sensory hair cells. In this study, we investigated whether hUCMSCs could 
differentiate into inner ear hair cells via adenoviral mediated g ne delivery of the 
Math1 gene. To induce differentiation, hUCMSCs were transduced with the 
AdMath1.11D vector in the presence of protamine sulfate as a cross-linking agent. 
Differentiated cells were characterized based on their morphology and 
immunocytochemistry. Additionally, gene expression was quantified via quantitative 
RT-PCR. Moreover, the in vitro capability of the differentiated hair cell-like cells to 
repair damaged epithelial cells was demonstrated by co-culturing w th neomycin-
treated murine macular organs. The results demonstrated for the first time that 
hUCMSCs can differentiate into hair cell-like cells, thus providing a new potential 
tissue engineering approach for treating hearing loss. 
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INTRODUCTION 
Sensory neural hearing loss (SNHL) and balance disorders are the most 
common hearing disabilities and affect approximately 49 million people in the United 
States. Loss of both auditory and vestibular hair cells is a cause of deafness. A cell 
source that has the potential to regenerate inner ear hair cells would have tremendous 
potential in clinical applications. Cells from the Wharton’s jelly of umbilical cords 
are believed to be multipotent mesenchymal stem cells that can differentiate into cell 
types from all three germ layers (122). Studies have documented i  vitro 
differentiation of these human umbilical cord mesenchymal stromal cel s 
(hUCMSCs) into osteocytes, chondrocytes, hepatocytes, adipocytes, neural cells, and 
pancreatic cells (126-129). hUCMSCs can be a valuable tool for gene deliv ry and 
tissue engineering applications. Differentiation of hUCMSCs into nerve tissue raises 
the possibility of differentiating them into sensory hair cells. Recent work has shown 
that inner ear progenitor cells can be generated from bone marrow mesenchymal stem 
cells by using a combination of growth factors and expression of the Math1 
transcription factor (68). Several studies in inner ear gene therapy h ve reported 
successful delivery of the Math1 gene using adenoviral vectors (14, 35, 36, 38, 49). 
Adenoviruses offer high transfection efficiencies and have substantial clinical 
experience, which makes them suitable for clinical use. We therefor  valuated the 
potential of hUCMSCs to express the Math1 gene and differentiate into hair cells.  
In this study, using an adenoviral gene delivery approach to express the Math1 
transcription factor in hUCMSCs, we induced hair cell differentiation. We then 
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examined the potential of differentiated cells to repair damaged sensory epithelium by 
co-culturing with murine macular organs. 
 
MATERIALS AND METHODS 
Isolation and expansion of hUCMSCs  
hUCMSCs were isolated from human umbilical cords according to protocols 
approved by the University of Kansas Human Subjects Committee (KU-Lawrence 
IRB approval # 15402, KU Medical Center IRB approval # 10951). The cords were 
obtained from the hospital and harvested within 24 hours after delivery. The cords 
were rinsed in phosphate buffered saline (PBS) and cut into small pieces of 2 to 3 cm. 
The vascular tissue was then removed, and the cords were minced and incubated in 
0.2% type II collagenase (298 U/mg; Worthington Biochemical; Lakewood, NJ) in 
low glucose Dulbecco’s modified Eagle’s medium (DMEM) for 4 hours at 37°C on a 
shaker. The digested homogenous solution was diluted in sterile PBS at a 1:4 ratio 
and centrifuged for 5 minutes at 1100 rpm. The supernatant was discarded nd the 
cells frozen for future use. Frozen hUCMSCs were thawed, plated at a density of 
7,000 cells/cm2, and cultured in low glucose DMEM with 10% fetal bovine serum 
(FBS-MSC quantified) and 1% penicillin/streptomycin (Invitrogen Life 
Technologies, Carlsbad, CA). Cells were fed every 2 days and maintained in a cell 
culture incubator at 37°C. At 80 - 90% confluency, the cells were trypsinized and 
passaged. hUCMSCs were isolated from 4 different human umbilical cords (n = 4)
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and expanded to passage 4 (P4) for the experiments. All experiments were performed 
in quadruplicate for each cord. 
 
Adenoviral vectors and vector production 
The Ad5 (AdMath1.11D) vector backbone had E1, E3 and E4 regions deleted 
with an expression cassette of Math1 driven by human cytomegalovirus (hCMV) 
promoter. The production system for the vector provided robust replication of the 
adenovector and purified stocks at 5 X 1011 and 2 X 1012 total particle units/ml 
(pu/ml), with a total particle to particle ratio ranging from 3 to 10 pu/fluorescent 
focus units. Total particle units were determined by spectrophotometric assay that has 
been standardized and qualified to reliably and robustly quantify the to al particles 
within a single lot of adenovector. The adenovector lots were purified, aliquoted, and 
stored at -80°C. Individual aliquots were used for each experiment to prevent loss of 
activity associated with freeze-thaw cycles. The expression cassette contained an 
open reading frame and an SV40 polyadenylation site and transcriptional st p site at 
3’ end of the open reading frame (GenVec Inc., Gaithersburg, Md., USA) as 
previously described (38, 112). 
 
Adenoviral transduction of hUCMSCs 
hUCMSCs were trypsinized at P4 and the cells were plated in an 8 well 
Millicell EZ Slide (Millipore, Billerica, MA) at 1,000 cells/well (n=4) and 500 µl
hUCMSCs medium (low glucose DMEM, 10% FBS, 1% penicillin/streptomycin) 
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was added per well. For RT-PCR, cells were plated in 12 well plates at 5,000 
cells/well (n = 4) and 1000 µl of hUCMSCs medium was added. Cells were allowed 
to attach for 24 hours before the virus was added directly to the mediu  at a 
multiplicity of infection (MOI) of 100 in the presence of 8 µg/ml of protamine sulfate 
(MP Biomedicals, Irvine, CA) (107, 113). Controls had every component added but 
the vector. The chamber slide/well plate was gently rocked after dding the vector 
and incubated at 37°C. The medium was changed after 24h and every 48h for the 
remaining culture period. The cells were cultured in vitro for 10 days and 
immunostained for hair cell specific and neuronal markers.   
 
Immunocytochemistry 
Cells were fixed for 10 minutes with 4% paraformaldehyde in PBS. This was 
followed by washing three times in PBS. Immunostaining was initiated by blocking 
the slides for 1 hour with 5% FBS followed by four 0.2% Tween washes. The cells 
were then permeabilized with 0.2% Triton X-100 for 10 minutes. Hair cell 
differentiation in culture was characterized by immunostaining with the hair cell 
specific marker myosin VIIa and the glial cell marker GFAP, and the neuronal marker 
neurofilament. Double antibody staining was performed by adding two primary 
antibodies together - rabbit polyclonal to myosin VIIa (1:100) (Proteus Biosciences, 
Ramona, CA) and chicken polyclonal to GFAP (1:100) (Abcam, Cambridge, MA). 
Mouse monoclonal to neurofilament (Invitrogen, Carlsbad, CA) was stained 
separately at a 1:100 dilution. The cells were incubated overnight at 4°C. Incubation 
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was followed by four washes with 0.2% Tween and secondary antibody incubation 
for 30 minutes at room temperature. The secondary antibodies with Alexa visualizing 
fluorescent signals (1:400) used were Alexa-555-conjugated goat anti-rabbit IgG, 
Alexa-488-conjugated goat anti-chicken IgG and Alexa-555-conjugated goat anti-
mouse IgG (all from Molecular Probes, Eugene, OR). All incubations were done in a 
humidified chamber. Incubation was followed by four washes with 0.2% Tween. The 
slides were mounted in ProLong Gold antifade with DAPI (4',6-diamidino-2-
phenylindole) (Invitrogen Life Technologies, Carlsbad, CA) and cover slipped. 
Microscopic images of cells counterstained with DAPI were acquired using an 
upright fluorescent microscope (Nikon Eclipse E800 and Q Image Aqua camera) and 
QCapture software. Images were photomerged and analyzed with Adobe Ph toshop 
CS5 extended (Adobe Systems, San Jose, CA). 
 
FM1-43 staining and fixation 
FM1-43 FX (Invitrogen, Carlsbad, CA) is a lipophilic dye that has been 
shown to enter hair cells through transduction channels and is used to detect active 
transducer channels in the differentiated hair cell-like cells (130, 131). 5 µg/ml of 
FM1-43 FX staining solution was prepared in ice cold Hanks' Balanced Salt solution 
(HBSS) (Sigma-Aldrich, St. Louis, MO). The cells were quickly stained for 1 min in 
the staining solution. The cells were then fixed in ice cold 4% paraformaldehyde in 
HBSS for 10 minutes on ice. This was followed by three rinses in HBSS. The slides 
were mounted in ProLong Gold antifade with DAPI (Invitrogen Life Technologies, 
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Carlsbad, CA) and cover slipped. Microscopic images of cells counterstained with 
DAPI were acquired using an upright fluorescent microscope (Nikon Eclipse E800 
and Q Image Aqua camera) and QCapture software. Images were photomerged and 
analyzed with Adobe Photoshop CS5 extended (Adobe Systems, San Jose, CA). 
 
Quantitative RT-PCR 
Total RNA from the controls and samples was extracted at day 10 post 
transduction using RNAeasy Mini kit (Qiagen, Valencia, CA) according to the 
manufacturer’s instructions. Isolated RNA was converted to cDNA using a TaqMan 
High Capacity kit (Applied Biosystems, Foster City, CA) in a  BioRad i-cycler 
thermal cycler (BioRad, Hercules, CA). Real time PCR was performed using SYBR 
green PCR Master Mix (BioRad, Hercules, CA) and an i-cycler (BioRad, Hercules, 
CA). PCR analysis was performed using cDNA as a template using custom designed 
primers for the following genes: glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH), myosin VIIa, nestin, glial fibrillary acidic protein (GFAP), sex 
determining region Y-box 2 (Sox2) and paired box gene 2 (Pax2). Primers were 
designed using Beacon Designer 7.9. Table 5.1 gives the list of primer pairs used and 
their cDNA product lengths. Custom primers were ordered from Integra ed DNA 
Technologies (Coralville, IA). A 2−∆∆Ct method was used to evaluate the relative level 
of expression for each target gene. Gene expression was normalized to controls and 
GAPDH.  
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LIVE/DEAD Assay for cell viability 
Cell viability at day 3 post transduction was assessed using a LIVE/DEAD 
assay kit for cell viability (molecular Probes, Eugene, OR). hUCMSCs at P4 from 
each of the four cords were plated in a 24 well plate at 5,000 cells/well (n =3). Cells 
were incubated with LIVE/DEAD reagent (dye concentration 2mM Calcein AM and 
4 mM Ethidium Bromide) for 10 minutes at 37°C in the dark. Cells were imaged 
using an inverted fluorescent microscope (Nikon, Melville, NY) and QCapture 
software. 
 
Co-culture of AdMath1.11D transduced hUCMSCs with murine macular organs 
Macular organs from mice were harvested as previously described (38). Adult 
C57B16 mice (12 months old, male and female) were sacrificed with intraperitoneal 
beuthanasia and decapitated under approved IACUC protocol (# 2008-1746). The otic 
capsule was exposed, and the macular organs were identified by finding the otolithic 
membranes. Using no. 5 watchmaker forceps, the saccule and utricle were removed. 
The organs were cultured on a Millicell membrane (Milli-pore Corp., Bedford, MA) 
suspended in 2,000 µl of Dulbecco modified Eagle medium supplemented with N1 
(Sigma, St.Louis, MO) + 100U/ml penicillin and 5.5 µl /mL of 30% glucose. After 24 
hours in vitro (37°C, 5% carbon dioxide), cultures were treated with 10-3 mol/L 
neomycin for 48 hours. Experimental cultures (n = 4 per experimental group) were 
treated with previously transduced hUCMSCs. Math1 gene expressing cells and GFP 
expressing cells were obtained from AdMath1.11D and Ad28.eGFP transduced 
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hUCMSCs cultures respectively. The cells were trypsinized at day 10 post 
transduction and suspended in organ culture medium at 50,000 cells/mL. 250 µl of 
this suspension was added to each macular organ (63). Negative control cultu es were 
placed in a medium not treated with neomycin and no cells were added. A second 
negative control culture was placed in complete medium without neomycin and no 
cells were added. Positive control cultures were treated with GFP expressing 
hUCMSCs. Organ cultures were incubated in a CO2 incubator at 37°C for 10 days 
with medium changes every 3 days. 
 
Immunostaining 
At day 10, explants were washed in PBS and fixed in 4% paraformaldehyde 
for 10 minutes. This was followed by three PBS washes. Immunostaining was 
initiated by blocking and permeabilizing explants in 10% FBS and 0.3% Triton X-
100 for 30 minutes. This was followed by incubation with primary antibody (1:500) 
at 4°C overnight. The primary antibody used was rabbit polyclonal to myosin VIIa 
(Proteus Biosciences, Ramona, CA). The explants were washed thrice with PBS and 
incubated in secondary antibody (1:400) for 30 minutes. The secondary antibody with 
Alexa visualizing fluorescent signals used was Alexa-555-conjugated goat anti rabbit 
IgG (all from Molecular Probes, Eugene, OR). All incubations were done in a 
humidified chamber. This was followed by three PBS washes again. The explants 
were mounted on Superfrost/Plus microscope slides (Fisher Scientifi, Pittsburgh, 
PA) using ProLong Gold antifade with DAPI (Invitrogen Life Technologies, 
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Carlsbad, CA) and cover slipped. Microscopic images of explants were acquired 
using an upright fluorescent microscope (Nikon Eclipse E800 and Q Image Aqua 
camera) and QCapture software. Images were analyzed with Adobe Photoshop CS5 
extended (Adobe Systems, San Jose, CA). 
 
RESULTS 
Characterization of hair cell like differentiation of hUCMSCs in vitro 
Differentiated cells (n = 4) from hUCMSC cultures were characterized based 
on morphology and immunocytochemistry. Spindle-shaped fibroblast-like cells
(characteristic morphology of hUCMSCs) were observed in the negativ  controls; 
however, the transduced cell populations showed a small percentage of pear-shaped 
cells with extended protrusions resembling the ciliary bundles in hair cells. These 
cells had centrally located nuclei. The ciliary protrusions and cytoplasm of the pear-
shaped cells were positive for myosin VIIa and GFAP antibodies (Figure 5.1). In 
addition, FM1-43 fluorescent labeling was observed in a small percentage of 
transduced cells (Figure 5.2). The transduced cells did not stain positive for the 
neurofilament antibody (Figure 5.3). 
 
Quantification of gene expression 
Untreated hUCMSCs were used as controls. All relative gene expression 
values for each target gene were normalized to controls and GAPDH. Expression of 
myosin VIIa was detected in the transduced cell population at day 10, although 
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controls also showed low levels of myosin VIIa expression. Transduced hUCMSCs 
demonstrated a small change in gene expression when compared to the controls. 
Nestin expression was detected in the transduced cells; however, nestin expressed 
high standard deviations when compared to other genes. Sox2 and Pax2 expressions 
were detected at PCR amplification cycles close to 35. There was no significant 
difference in the gene expression levels of myosin VIIa, nestin, Pax2 and Sox2 
between the control and transduced groups.  GFAP expression failed to show up on 
real time PCR analysis (Figure 5.4).  
 
Transduced cell viability 
Cell viability was determined with Calcein AM (green) and Ethidium 
Bromide (red) fluorescent markers. Green color indicated live cells, while the red 
color indicated dead cells. hUCMSCs transduced with the AdMath1.11D vector at a 
multiplicity of infection of 100 demonstrated high cell viabilities at 3 days post 
transduction, indicating low cytotoxic effects of adenoviral mediate gene delivery in 
hUCMSCs (Figure 5.5). 
 
Co-culture of AdMath1.11D transduced cells and macular organ explants 
We investigated the potential of AdMath1.11D transduced hUCMSCs to 
repair damaged sensory epithelium in macular organ explants. After 10 days of co-
culture with macular organs, hair cell-like cells were found in one of the four explants 
(Figure 5.6). Negative controls without neomycin showed the presence of hair cells in 
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the sensory epithelium. Negative controls with neomycin treatment did not show any 
myosin VIIa positive hair cells due to the absence of hair cells. In addition, the 
positive controls failed to show any migration of GFP expressing hUCMSCs (Figure 
5.6). 
 
DISCUSSION 
hUCMSCs are believed to be multipotent stem cells and have been reported to 
differentiate into multiple cell lineages belonging to all three g rm layers. hUCMSCs 
have been shown to give rise to cells from chondrogenic, osteogenic, myogenic, 
adipogenic, neurogenic, hepatogenic, and pancreatic lineages (126-129, 132). In this 
study, we demonstrated the possibility of extending the range of lineages for 
hUCMSCs to include inner ear sensory hair cells. Studies of Math1 expression in 
inner ear progenitor cells have indicated that this transcription factor plays an 
important role in the differentiation of hair cells (33). Studies with rat bone marrow 
mesenchymal stem cells have demonstrated their potential to express Math1 and 
differentiate into inner ear progenitor cells in the presence of otic-inducing growth 
factors (68). 
Our results show that hUCMSCs infected with an adenovector can express the 
Math1 transcription factor driven by the human cytomegalovirus (hCMV) promoter, 
and differentiate into hair cell-like cells. Studies with mesenchymal stem cells have 
indicated that a stem cell that has differentiated partially or completely into an inner 
ear progenitor cell can express early otic, hair cell, and neuronal markers (125). 
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Immunocytochemical results on the transduced cell population in our experiments 
demonstrated differentiated cells that expressed the hair cell-specific markers myosin 
VIIa and FM1-43 and the glial cell marker GFAP. Myosin VIIa is a hair cell-specific 
marker that stains actin binding domains in myosin motor proteins present in the 
transduction channels (11). GFAP is an astrocyte marker expressed in sensory 
epithelial cells in the inner ear (133). Differentiated cells were characterized 
anatomically and immunocytochemically. Myosin VIIa and GFAP positive cells were 
pear-shaped and displayed protrusions at one end that resembled ciliary bundles in 
hair cells. Cell morphology indicated differentiation into hair cell-like cells, and 
positive expressions of myosin VIIa and GFAP indicated immature featur s of hair 
cell precursor cells and neuroepithelial cells (133). FM1-43 positive stains indicated 
the presence of active transducer channels in the hair cell-like cells. The differentiated 
cells did not express the neuronal marker neurofilament indicating that the Math1 
gene did not induce any neuronal phenotypes. Only a small percentage of th
transduced cell population was observed to demonstrated hair cell morphology and 
gene expression. Previous research has shown that the notch signaling pathway can 
inhibit differentiation, resulting in the prevention of a hair cell fate commitment 
(125). This may be one of the reasons for low transduction efficiencies and partial 
differentiation of hUCMSCs. 
Quantitative gene expression results from RT-PCR demonstrated expression 
of myosin VIIa, nestin, Pax2, and Sox2. Although the PCR results demonstrated a 
certain level of gene expression, the reliability of the data in detecting minute levels 
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of gene expression may be compromised. Only a few cells in the en ir transduced 
population were reported to be differentiated and due to the lack of a selection gene i
the vector (AdMath1.11D) backbone, the differentiated cells could not be separated 
from the rest of the population for gene expression analysis. In our study, RNA was 
isolated from the entire cell population consisting of a mixture of differentiated and 
undifferentiated cells. Therefore, the chances of PCR detecting the desired gene are 
very bleak with the inclusion of the RNA from all of the undifferentiated cells. 
Immunocytochemistry results were positive for GFAP while RT-PCR failed to detect 
GFAP. This discrepancy may be because GFAP is reported to express only in cells 
that are partially or completely differentiated to sensory epith lium or 
neuroepithelium (133). The gene expression may have been at extremely low levels 
that were difficult to detect within the first few amplification cycles of RT-PCR. On 
the other hand, myosin VIIa was detected by RT-PCR. This can be explained from 
the low levels of myosin VIIa expressed in untreated hUCMSCs, though not 
sufficient enough to induce hair cell differentiation in hUCMSCs. We can therefore 
conclude that Math1 expression is important for inducing development of hair cell 
characteristics in hUCMSCs. 
Immunocytochemistry of transduced hUCMSCs and macular organ co-
cultures demonstrated the presence of myosin positive cells, indicat g the potential 
of hUCMSCs to engraft and integrate into the sensory epithelium. Experimental 
group treated with GFP expressing hUCMSCs failed to show GFP expression in 
sensory epithelium owing to the short term transient gene expression of GFP. 
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However, myosin positive hair cell-like cells were observed in onlye of the four 
explant co-cultures. This result may be explained as follows. It is possible that the one 
explant actually received a sufficient number of Math1 expressing cells and 
demonstrated its ability to regenerate hair cells in neomycin-treated macular organs, 
or the neomycin treatment failed to damage the hair cells in the sensory epithelium 
for this explant alone. Another possibility to consider is the multipotent properties of 
hUCMSCs and their capability of differentiating into hair cell-like cells responding to 
inductive signals from the surrounding cells in the sensory epithelium. Evaluation of 
the integration of differentiated cells in tissue can be challenging owing to the 
complex structure of the inner ear. More importantly, these results provide the basic 
information required for further in vitro and cell transplantation studies. Studies have 
demonstrated the successful co-culture of stem cells with cochlear explants (63, 68). 
Therefore, co-culturing cochlear explants with cells that are genetically manipulated 
in vitro to express Math1 using viral vectors can potentially be used to regenerate 
inner ear hair cells.  
The findings in this study indicated that hUCMSCs may have the potential to 
differentiate into inner ear sensory cells for use as a source of transplantation in 
curing SNHL and other hearing disorders. Stem cells in the inner ear lack the capacity 
to differentiate and replace damaged hair cells (27) and therefore a cell source like 
hUCMSCs with the capacity to express Math1 can be used in therapeutic 
applications. Our findings suggest for the first time that hUCMSCs can differentiate 
into hair cell-like cells via the adenoviral mediated gene delivery of Math1, thus 
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providing a significant finding in the field of tissue engineering and a potential 
strategy to cure sensory neural hearing loss. 
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CHAPTER 6: Conclusion 
Previous studies that attempted to regenerate inner ear hair cells have 
successfully differentiated embryonic and mesenchymal stem cells using a 
combination of several otic-inducing growth factors or by expression of an externally 
delivered Math1 gene. The studies in this thesis made the first attempt in using 
mesenchymal stem cells from human umbilical cord stroma for regenerating hair 
cells. Our results examined the potential use of human umbilical cord mesenchymal 
stromal cells (hUCMSCs) in stem cell-based and tissue engineering approaches to 
restore hearing loss. 
Hair cell differentiation in hUCMSCs was induced in vitro via adenoviral 
mediated gene delivery of the Math1 gene. The differentiated cells resembled hair 
cells based on morphology and immunocytochemical markers. Differentiated cells 
expressed hair cell specific markers myosin VIIa and FM1-43 and the glial cell 
marker GFPA. The findings indicated the development of hair cell-lik  cells. 
However, transduction efficiencies were low and only a small percentag  of the cells 
differentiated into hair cell-like cells. This may suggest partial differentiation of stem 
cells. The notch signaling pathway, Hes1, Hes5, and Jagged1 genes are known to be 
potent down regulators of Math1 expression. They cause lateral inhibition wherein 
one cell is singled out from a group of cells for a given fate.  Notch signaling inhibits 
Math1 gene expression and hair cell differentiation, preventing a cell from 
committing to the hair cell fate. Future work can investigate the application of notch 
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inhibitors like γ-secretase inhibitors at varying concentrations to prevent the la eral 
inhibition caused by notch signaling. 
Future studies with the use of hUCMSCs for hair cell differentiation can focus 
on delivering adenoviral vectors at high multiplicity of infection ad using a 
combination of growth factors like IGF-1, NT-3, bFGF, EGF, and BDNF to 
supplement the differentiation process and achieve a higher percentage of 
differentiated cells. Although, MOIs greater than 100 may cause random integration 
of virus into host chromosome and generate replication competent viruses and voke 
immune responses. Co-culturing partially differentiated cells with inner ear sensory 
epithelial cells may also induce differentiation in stem cells. Additionally, a vector 
designed to contain an antibiotic selection marker can be used to isolate the 
differentiated cells from the transduced population and test their potential to 
regenerate hair cells in vivo. Fluorescence activated cell sorting (FACS) analysis can 
be considered to isolate differentiated cells from the transduced population. 
Quantitative RT-PCR on an isolated, differentiated cell population would give a more 
representative analysis of the target genes expressed than the data obtained in this 
thesis. Regardless, the success achieved with hUCMSCs in thisthes  work has laid a 
foundation to explore numerous ways of inducing hair cell differentiation. This thesis 
examined the potential of hUCMSCs as a possible source to enginer in r ear hair 
cells to restore hearing loss. In the future, cell transplantatio  treatments for hearing 
loss may include the delivery of a pure, differentiated hUCMSC population to the 
inner ear, with or without the augmentation of growth factors. 
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Figure 2.1: Classification of inner ear sensory epithelium. 
Sensory epithelium in the inner ear is composed of both sensory and non sensry c ll 
types that have morphological and physiological differences. 
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Figure 2.2: Structure of a typical hair cell. 
Schematic representation of a hair cell, showing the flask-shaped hair cell supported 
by supporting cells at the base. The stereocilia at the top are connected by filamentous 
tip links that participate in transduction and ion exchange. 
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Figure 2.3: Schematic on the interaction of different genes and their contribution to 
positive and negative regulation of Math1 transcription factor.  
(A) Hair cells express hair cell-specific Math1 transcription factor and notch ligands – 
Delta1 and Jagged2. Notch receptor (N) binds to the ligands, cleaves with the help of 
γ-secretase and releases Notch Intracellular Domain (NICD). NICD enter the nucleus 
of supporting cells and activated Hes1/Hes5 transcription factors. Hes1/Hes5 proteins 
inhibit Math1 gene expression. Alternatively, expression of p27kip1 and p19Ink4d in 
early progenitor supporting cells repress Math1 expression and maintain supporting 
cell fate. (B) In the presence of γ-secretase inhibitors and targeted deletion of p27kip1 
and p19Ink4d genes, ectopic expression of Math1 occurs producing supernumerary hair 
cells. 
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Figure 3.1: Adenoviral mediated expression of GFP in hUCMSCs transduced with 
Ad28.eGFP vector at 3, 5 and 10 days post transduction. 
The figure shows the effect of MOI on the expression level of introduced GFP. 
Vertical panels (A-C), (D-F) and (G-I) represent transient gene expression at days 3, 
5 and 10 respectively. Horizontal panels (A, D, G), (B, E, H) and (C, F, I) represent 
the effect of MOIs 10, 50 and 100 respectively on the expression level of adenovirally 
introduced GFP. Note that maximum gene expression was at day 5 and at MOI 100. 
The figures represent a random microscopic field for one cord. The results were 
consistent among cords. Scale bar = 100 µm. 
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Figure 3.2: Adenoviral mediated expression of GFP in hUCMSCs transduced with 
Adf11D.eGFP vector at 3, 5 and 10 days post transduction. 
The figure shows the effect of MOI on the expression level of introduced GFP. 
Vertical panels (A-C), (D-F) and (G-I) represent transient gene expression at days 3, 
5 and 10 respectively. Horizontal panels (A, D, G), (B, E, H) and (C, F, I) represent 
the effect of MOIs 10, 50 and 100 respectively on the expression level of adenovirally 
introduced GFP. Note that maximum gene expression was at day 5 and at MOI 100. 
The figures represent a random microscopic field for one cord. The results were 
consistent among cords. Scale bar = 100 µm. 
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Figure 4.1: Characterization of Math1 gene expression by immunostaining with 
myosin VIIa in hUCMSCs transduced with the AdMath1.11D vector 
(A-D) controls from each cord that did not have any vector treatment. (E-H) myosin 
VIIa positive cells from each cord. Vertical panels represent a randomly selected 
microscopic field for each cord. Cells were infected at MOI 100 and immunostained 
10 days post transduction. The position of nuclei is represented by DAPI staining 
(blue). Immunostaining indicated myosin VIIa positive cells (red) and hair cell-like 
cells. Scale bar = 20 µm.  
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Figure 4.2: Characterization of Math1 gene expression by immunostaining with 
myosin VIIa in hUCMSCs transduced with Ad28.GFAP.Atoh1 vector. 
(A-D) represent controls from each cord that did not have any vector treatment. (E-H) 
represent myosin VIIa positive cells from each cord. Vertical panels represent a 
randomly selected microscopic field for each cord. Cells were infected at MOI 100 
and immunostained 10 days post transduction. The position of nuclei is represented 
by DAPI staining (blue). Immunostaining demonstrated low levels of myosin VIIa 
expression (red). Scale bar = 20 µm. 
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Figure 4.3: Characterization of Math1 gene expression by immunostaining with 
myosin VIIa in hUCMSCs transduced with Ad5.GFAP.Math1 vector. 
(A-D) represent controls from each cord that did not have any vector treatment. (E-H) 
represent myosin VIIa positive cells from each cord. Vertical panels represent a 
randomly selected microscopic field for each cord.  Cells were infected at MOI 100 
and immunostained 10 days post transduction. The position of nuclei is represented 
by DAPI staining (blue). Immunostaining demonstrated low levels of myosin VIIa 
expression (red). Scale bar = 20 µm. 
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Figure 5.1: Characterization of hair cell-like cells in hUCMSC culture transduced 
with AdMath1.11D vector using specific hair cell and glial cell markers. 
(A-D) controls from each cord that did not have any vector treatmnt. (E-H) myosin 
VIIa and GFAP positive cells from each cord. Vertical panels represent a randomly 
selected microscopic field for each cord. Cells were infected a MOI 100 and 
immunostained 10 days post transduction. The position of nuclei is represented by 
DAPI staining (blue). Immunostaining demonstrated myosin VIIa and GFAP positive 
pear-shaped cells with an extended protrusion at one end, similar in appear nce to 
inner ear hair cells. Yellow color indicates expression of myosin VIIa and GFAP in 
differentiated cells.  Scale bar = 20 µm. 
 73
 
Figure 5.2: Characterization of hair cell-like cells in hUCMSC culture transduced 
with AdMath1.11D vector using specific hair cell marker – FM1-43. 
(A-D) controls from each cord that did not have any vector treatmnt. (E-H) FM1-43 
positive cells from each cord. Vertical panels represent a randomly selected 
microscopic field for each cord. Cells were infected at MOI 100 and immunostained 
10 days post transduction. The position of nuclei is represented by DAPI staining 
(blue). FM1-43 labels stereocilia transduction channels in hair cells (green) indicating 
transduction activity in differentiated hair cell-like cells. Scale bar = 20 µm. 
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Figure 5.3: Characterization of neuronal expression by immunostaining with 
neurofilament in hUCMSCs transduced with AdMath1.11D vector. 
(A) control that did not have any vector treatment. (B) transduced cells that did 
not show neurofilament positive cells, indicating an absence of neural 
differentiation in Math1 transduced cells. Cells were infected at MOI 100 and 
immunostained 10 days post transduction. The position of nuclei is represented by 
DAPI staining (blue). The figures represent a random microscopic field for one 
cord. The results were consistent among cords. Scale bar = 20 µm. 
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Figure 5.4: Gene expression analysis of myosin VIIa, nestin, GFAP, Pax2 and Sox2 
All relative gene expression values for each target gene at day 10 post transduction 
were normalized to controls and GAPDH. Values are reported as me n ± standard 
deviation, n = 3. A low level of myosin expression was reported in transduced cells. 
There were no statistically significant differences in the gene expression levels of 
myosin VIIa, nestin, Pax2 and Sox2 between control and transduced group.  
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Figure 5.5: LIVE/DEAD images for AdMath1.11D transduced hUCMSCs. 
(A-D) represent controls from each cord that did not have any vector treatment. (E-H) 
represent hUCMSCs from each cord transduced with AdMath1.11D vector at MOI 
100 at day 3 post transduction. Live cells are stained green, while dead cells are 
stained red. The results demonstrated high cell viability in transduced cells indicating 
low cytotoxic effects of AdMath1.11D. Scale bar = 100 µm. 
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Figure 5.6: Co-culture of transduced hUCMSCs and macular organs. 
(A), (B) Negative controls without and with neomycin treatment respectively. Both 
the negative controls were not treated with cells. (C) Positive control that was treated 
with neomycin and GFP expressing hUCMSCs. (D) Experimental group that was 
treated with neomycin and differentiated hUCMSCs. Cultures were stained for 
myosin VIIa at day 10. The results demonstrated myosin VIIa positive cells (red) in 
experimental group. Arrows point to myosin VIIa positive cells. All figures represent 
one explant from each group. Scale bar = 20 µm. 
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Table 2.1: Differences between inner and outer hair cells 
FACTOR INNER HAIR CELLS 
OUTER HAIR 
CELLS 
Ref. 
Arrangement 
Arranged in a single 
row 
Arranged in three 
parallel rows 
(134-
136) 
Shape Round and small Long and slim (10) 
Function 
Transduce mechanical 
energy to neural signals 
Appear to impact the 
sensitivity of the 
cochlea 
(10) 
Effects 
Sensory Neural Hearing 
loss 
Alter properties of 
cochlear input to the 
brain 
(137) 
Approximate 
number 
3,000 to 3,500 9,000 to 12,000 
(135, 
136) 
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Table 2.2: Summary of different genes used in inner ear gene therapy 
Gene Role Reference 
Math1 
Also known as Atoh1. Primary gene responsible 
for hair cell differentiation. Other homologues 
include Hath1, Cath1 and Xath1. 
(33, 35, 39-
41) 
Hes1 and Hes5 
Mammalian homologues of Hairy and 
Enhancer-of-split gene. Expressed in supporting 
cells and known to be negative regulators of 
Math1. However, a balance between Hes1/Hes5 
is required to control the production of 
supernumerary hair cells and normal 
development of inner ear. 
(42, 43) 
Sox2 
Responsible for development of inner ear 
sensory epithelium and is expressed in 
supporting cells and inner ear progenitors. Acts 
upstream of Math1 and maintains mitotic and 
transdifferentiation functions of supporting 
cells. 
(138-140) 
Jagged2 
Member of the notch signaling pathway. 
Expressed in supporting cells of auditory and 
vestibular system. Required for the normal 
development of inner ear sensory organs. 
(17, 140, 
141) 
BETA2/NeuroD 
Expressed in neurons and neural precursor 
cells. Promotes the formation of ganglion 
neurons in the cochlea. Absence of 
BETA2/NeuroD can compromise hair cell 
function. 
(44)  
 81
pRb 
Required for cell-cycle exit of embryonic 
mammalian hair cells but not for their early 
differentiation. Deletion of pRb from progenitor 
cells leads to proliferation of hair cells and 
supporting cells. 
(142-144) 
p27kip1 and 
p19Ink4d 
Cyclin-dependent kinase inhibitor. Expressed in 
sensory progenitors during the early embryonic 
development of the cochlea. Regulates cell 
cycle and inhibits hair cell differentiation. 
(145-147) 
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Table 2.3: Summary of different viral vectors used in inner ear gene therapy  
Vector Advantages Disadvantages Ref. 
Adeno 
virus 
1) Transfect a wide variety of cell types 
in the inner ear including spiral 
ganglions, outer hair cells, spiral 
ligament, stria vascularis, and 
mesenchymal cells in both auditory 
and vestibular systems. 
2) Can produce high titer values that 
allow injection of small dose volumes 
for gene therapy. 
3) Transgene expression up to 3 weeks 
can be achieved. The short duration of 
gene expression is ideal for hair cell 
regeneration because prolonged Math1 
expression can produce too many 
ectopic hair cells and compromise 
hearing. 
4) Effective in delivering Math1 gene to 
regenerate hair cells and Bcl-2 to 
protect hair cells from damage. 
5) Allows insertion of large DNA 
segments. Recombinant forms can 
take up to 30kb foreign DNA. 
6) Infects dividing and non-dividing cells 
with very high transduction 
efficiencies, both in vitro and in vivo. 
7) Widely researched in clinical studies 
in both animals and humans, giving a 
better ability to tackle clinical 
complications that can arise. 
1) Evokes a strong host 
immune response. 
2) Does not offer long 
term gene expression. 
3) Entry of the viral 
vectors is largely 
dependent on a host 
receptor called the 
coxsackie virus 
receptor (CAR). 
(35, 
37, 
54-56, 
148, 
149) 
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Adeno-
associated 
Virus 
1) Effectively transfect most inner ear 
cell types in vivo. Studies show 
transgene expression in cochlear blood 
vessels, nerve fibers and spiral limbus 
cells. 
2) Effective in targeting stria vascularis 
and delivering tropic factors like NT-
3, BDNF, VEGF and FGF. 
3) Transgene expression can occur up to 
24 weeks in vivo. 
4) Non toxic to inner ear cells and evokes 
low immune response. 
5) Lacks pathogenicity and has never 
been associated with any known 
human disease making them suitable 
for clinical applications. 
1) Only effective with 
in vivo inner ear gene 
therapy. 
2) Successful transgene 
expression in vivo 
depends on route of 
vector 
administration, 
limited to only direct 
injection of vector. 
3) Previous studies have 
shown possible 
dissemination of 
vector from target 
tissue. 
4) Offers only a limited 
payload capacity 
owing to its small 
size. 
5) Risk of insertional 
mutagenesis. 
6) No substantial 
clinical experience. 
7) Vector entry in to 
host largely depends 
on heparin sulfate 
receptor. 
(48, 
150-
153) 
Herpes 
Simplex 
Virus 
1) Effectively known to target non 
dividing cells, specific to nerve cells, 
spiral ganglion, vestibular ganglion 
and mesenchymal cells in mice and 
guinea pigs. 
2) Newer recombinant vectors offer 
stable and long term gene expression 
of up to 8 weeks. 
3) Can take large DNA fragments. 
1) Evokes a strong 
immune response. 
2) Transfection is 
limited only to non 
dividing neuronal 
cells. 
3) Large size of the 
virus makes it 
difficult to 
(56, 
57, 
154) 
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manipulate. 
4) The virus does not 
integrate into the host 
genome; hence gene 
expression can be 
unstable. 
5) Difficult to produce 
high titer values and 
requires injection of 
high vector volumes. 
6) No substantial 
clinical experience. 
Lenti 
virus 
1) Transfect both dividing and non-
dividing cells, including stem cells that 
are very difficult to transfect. 
2) Effectively transduce spiral ganglion 
neurons and supporting cell in vitro. 
3) Studies indicate transgene expression 
in perilymphatic space for up to 2 
weeks. 
1) Limited to use in 
production of genes 
only in the 
perilymph. 
2) Limited 
dissemination of 
vector and not 
suitable for sensory 
cell transduction. 
3) Failure to transduce 
cells in vivo. 
4) Can randomly 
integrate into host 
chromosome and 
capable of generating 
a replication 
competent virus. 
5) No clinical 
experience and safety 
concern arise from 
human immune 
deficiency virus 
origin. 
(58, 
107) 
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Table 5.1: Primer pairs and cDNA product length 
Marker 
Forward primer sequence 5’ – 
3’ 
Reverse primer sequence 5’ 
– 3’ 
cDNA 
length 
Myosin 
VIIa 
GAGAGAGGGAGAGACAAG CTCTTCCTCTGTCTGGCT 100 bp 
Nestin GAAGATACGGTGGAGAAG CTTCCCAGTGAAGCCATC 120 bp 
GFAP AACTCCAACTAACAAGAA 
CATAACAACAGGAATCA
G 
151 bp 
Pax2 CTACACGCCCATTAAAGC TACAGAGAAGCCAACA 152 bp 
Sox2 
ATGGTTGTCTATTAACTTG
T 
TCTCTCCTCTTCTTTCTC 128 bp 
GAPD
H 
TAACTCTGGTAAAGTGAAT ACTTGATTTAGGGAT 191 bp 
 
